Detalhe da pesquisa
1.
New Pathway for Cisplatin Prodrug to Utilize Metabolic Substrate Preference to Overcome Cancer Intrinsic Resistance.
ACS Cent Sci
; 9(7): 1297-1312, 2023 Jul 26.
Artigo
Inglês
| MEDLINE | ID: mdl-37521786
2.
Correction to "New Pathway for Cisplatin Prodrug to Utilize Metabolic Substrate Preference to Overcome Cancer Intrinsic Resistance".
ACS Cent Sci
; 9(8): 1705, 2023 Aug 23.
Artigo
Inglês
| MEDLINE | ID: mdl-37637725